SCHEMBL394893

SCHEMBL394893

CCN(O)CC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3621765 0.97
Citric Acid SCHEMBL10492812 0.81 ALDH1A1 (0.58)
SCHEMBL185231 0.81 TDP1 (0.50)
SCHEMBL1052494 0.78
Ammonia Solution, Strong SCHEMBL10702616 0.78 TDP1 (0.47)
Glycolic Acid SCHEMBL5551767 0.77 FFAR3 (0.42)
Bicarbonate SCHEMBL27759468 0.77 FFAR3 (0.35)
SCHEMBL19063027 0.77
SCHEMBL21239560 0.76 TDP1 (0.61)
Oxalic Acid SCHEMBL6313261 0.75 FFAR3 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 694 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260140093-A1 METHODS, COMPOSITIONS AND KITS FOR CONCENTRATING TARGET ANALYTES FROM A BULK FLUID SAMPLE PHASE SCIENT INTERNATIONAL LTD (CN) 2026-05-21 US claimed
US-20250333777-A1 METHODS AND KITS FOR ISOLATING CELL-FREE DNA OR CIRCULATING FETAL DNA FROM URINE SAMPLES PHASE SCIENT INTERNATIONAL LTD (CN) 2025-10-30 US claimed
EP-4612290-A1 METHODS AND KITS FOR ISOLATING TARGET NUCLEIC ACIDS BELOW A TARGET SIZE FROM A SAMPLE Phase Scientific International, Ltd. (HK) 2025-09-10 EP claimed
EP-4612288-A1 METHODS FOR ISOLATING TARGET ANALYTES FROM BIOLOGICAL SAMPLES USING ATPS AND SOLID PHASE MEDIA Phase Scientific International, Ltd. (HK) 2025-09-10 EP claimed
EP-4613912-A1 CATHODE MATERIAL FOR SOLID OXIDE ELECTROLYTIC CELL, AND PREPARATION METHOD THEREFOR AND USE THEREOF China Petroleum & Chemical Corporation (CN) 2025-09-10 EP claimed
EP-4612289-A1 METHODS, COMPOSITIONS AND KITS FOR CONCENTRATING TARGET ANALYTES FROM A BULK FLUID SAMPLE Phase Scientific International, Ltd. (HK) 2025-09-10 EP claimed
US-12258616-B2 Methods and kits useful for diagnosis of human papillomavirus (HPV) Phase Scientific International, Ltd. (CN) 2025-03-25 US claimed
US-20250027137-A1 METHODS AND KITS USEFUL FOR DIAGNOSIS OF HUMAN PAPILLOMAVIRUS (HPV) Phase Scientific International, Ltd. (CN) 2025-01-23 US claimed
US-20250027138-A1 METHODS AND KITS USEFUL FOR DIAGNOSIS OF UROGENITAL CANCER Phase Scientific International, Ltd. (CN) 2025-01-23 US claimed
US-20250011838-A1 METHODS FOR ISOLATING TARGET ANALYTES FROM URINE SAMPLES USING ATPS AND MAGNETIC BEADS Phase Scientific International, Ltd. (CN) 2025-01-09 US claimed
US-20070187102-A1 Hydraulic fracturing methods using cross-linking composition comprising delay agent E. I. DU PONT DE NEMOURS AND COMPANY 2007-08-16 US claimed
US-20070187642-A1 Zirconium cross-linking composition and methods of use E. I. DU PONT DE NEMOURS AND COMPANY 2007-08-16 US claimed
US-20070191233-A1 Cross-linking composition and method of use DORF KETAL SPECIALITY CATALYSTS, LLC 2007-08-16 US claimed
EP-1292759-B1 PROCESS FOR ALTERING THE RELATIVE PERMEABILITY OF A HYDROCARBON-BEARING FORMATION TR OIL SERVICES LTD (GB) 2004-09-22 EP claimed
EP-1222164-B1 PROCESS FOR THE PRODUCTION OF 5-SULFO ISOPHTHALATE BIS-GLYCOLATE ESTER METAL SALTS AND OXYSULFONATED POLYESTERS MADE THEREFROM DU PONT (US) 2004-02-25 EP claimed
EP-0857164-A4 NITROGENOUS STRENGTH ENHANCERS FOR PORTLAND CEMENT GRACE W R & CO (US) 1999-10-20 EP claimed
EP-0857164-A1 NITROGENOUS STRENGTH ENHANCERS FOR PORTLAND CEMENT W.R. Grace & Co.-Conn. (US) 1998-08-12 EP claimed
US-5641352-A Nitrogenous strength enhancers for portland cement W.R. GRACE & CO.-CONN. (US) 1997-06-24 US claimed
WO-1997015535-A1 NITROGENOUS STRENGTH ENHANCERS FOR PORTLAND CEMENT W.R. GRACE & CO.-CONN. (US) 1997-05-01 WO claimed
US-4914232-A FOR POLYMERS THE B. F. GOODRICH COMPANY (US) 1990-04-03 US claimed